• Skip to primary navigation
  • Skip to main content
  • Skip to primary navigation
  • Skip to main content
Choose which site to search.
UAMS Health Logo UAMS Health
  • UAMS.edu
  • MyChart
  • Giving
  • Emergency Room
  • COVID-19
  • Types of Care
  • Locations
  • Doctors
  • Patients & Guests
  • Referring Physicians
  • Appointments
  1. UAMS Health
  2. Clinical Resources
  3. Dr. Van Rhee on Future Research Directions for CAR T-Cell Therapy in Multiple Myeloma

Clinical Resource: Dr. Van Rhee on Future Research Directions for CAR T-Cell Therapy in Multiple Myeloma

Description

Frits van Rhee, M.D., Ph.D., professor and director of the Myeloma Center at the University of Arkansas for Medical Sciences, and Charles and Clydene Scharlau Chair for Hematological Malignancies, discusses future research directions with CAR T-cell therapy for the treatment of patients with multiple myeloma.  This was published at OncLive on Sep. 3, 2021.

Video Player

Dr. Van Rhee on Future Research Directions for CAR T-Cell Therapy in Multiple Myeloma.

Transcript

First of all, [we must determine how to best] fit this therapy into the existing treatment algorithm of myeloma. One could foresee giving this therapy early, for instance, in patients who have an early relapse on frontline therapy. Perhaps the CAR T cells could also be used for patients who are diagnosed with quite aggressive disease. They could be given as an additional therapy up front and perhaps even at some stage as a replacement of autologous stem cell transplantation.

The other major opportunity is to understand how we can approve upon the existing CAR T-cell therapies. One of the reasons CAR T-cell therapy is so exciting is that the results [we have were] obtained with the first generation of [products]. We need to better understand how we can make the CAR T cells better persist in patients, how we can make them survive longer, and how we can [prolong] their antimyeloma effect. [We also need to understand what] allows myeloma cells to escape from CAR T-cell therapy and how the bone marrow microenvironment affects the efficacy of CAR T cells.

Related Content

  • Conditions
  • Providers
  • Locations
  • Areas of Expertise
  • Make an Appointment

Related Conditions

  • Multiple Myeloma

Related Providers

Frits van Rhee, M.D., Ph.D.

Frits van Rhee, M.D., Ph.D. Hematologist/Oncologist

View Profile

Related Locations

Myeloma Center

Myeloma Center

449 Jack Stephens Drive
Winthrop P. Rockefeller Cancer Institute
Little Rock, AR 72205

Appointment Phone Numbers
501-686-7105
New Patients
501-686-8230
Returning Patients
View Location Get Directions

Related Areas of Expertise

Image of male doctor giving intravenous drip chemotherapy treatment to a female cancer patient.

Cancer Care

The UAMS Winthrop P. Rockefeller Cancer Institute is Arkansas’ most comprehensive cancer treatment and research facility.

View Area of Expertise
Multiple Myeloma Center at UAMS

Myeloma Care (Part of Cancer Care)

The UAMS Myeloma Center is the most comprehensive center in the world for research and clinical care related to multiple myeloma.

View Area of Expertise

Make an Appointment

Request an appointment by contacting a clinic directly or by calling the UAMS Health appointment line at (501) 686-8000.

UAMS Health LogoUAMS HealthUniversity of Arkansas for Medical Sciences
Mailing Address: 4301 West Markham Street, Little Rock, AR 72205
Phone: (501) 686-7000
  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • LinkedIn
  • Pinterest
  • Disclaimer
  • Terms of Use
  • Privacy Statement
  • Notice of Privacy Practices

© 2023 University of Arkansas for Medical Sciences

Please share your location to continue